» Articles » PMID: 8339731

Radioimmunoscintigraphy with Technetium-99m-labelled Monoclonal Antibody, SM3, in Gynaecological Cancer

Overview
Journal Eur J Nucl Med
Specialty Nuclear Medicine
Date 1993 Jun 1
PMID 8339731
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Radioimmunoscintigraphy (RIS) with technetium-99m labelled SM3, a monoclonal antibody reacting with a polymorphic epithelial mucin glycoprotein core antigen, is evaluated. No adverse effects or thyroid uptake were observed. Studies in 45 patients (one twice) had a sensitivity for gynaecological malignancy of 100% (35/35) and a specificity of 73% (8/11), giving an overall accuracy of 93% (43/46). These results have led to the routine adoption of 99mTc RIS in the management of patients suspected of or having primary or recurrent gynaecological cancer.

Citing Articles

Recent trends in antibody-based oncologic imaging.

Kaur S, Venktaraman G, Jain M, Senapati S, Garg P, Batra S Cancer Lett. 2011; 315(2):97-111.

PMID: 22104729 PMC: 3249014. DOI: 10.1016/j.canlet.2011.10.017.


99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection.

Biassoni L, Granowska M, Carroll M, Mather S, Howell R, Ellison D Br J Cancer. 1998; 77(1):131-8.

PMID: 9459158 PMC: 2151258. DOI: 10.1038/bjc.1998.21.


Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.

Stalteri M, Mather S Eur J Nucl Med. 1996; 23(2):178-87.

PMID: 8925853 DOI: 10.1007/BF01731842.


Effect of circulating antigen on immunoscintigraphy of ovarian cancer patients using anti-CA125 monoclonal antibody.

Sakahara H, Hosono M, Kobayashi H, Yao Z, Saga T, Yano S Jpn J Cancer Res. 1996; 87(6):655-61.

PMID: 8766531 PMC: 5921138. DOI: 10.1111/j.1349-7006.1996.tb00273.x.


Peroperative radioimmunodetection of ovarian carcinoma using a hand-held gamma detection probe.

Ind T, Granowska M, Britton K, Morris G, Lowe D, Hudson C Br J Cancer. 1994; 70(6):1263-6.

PMID: 7981086 PMC: 2033666. DOI: 10.1038/bjc.1994.484.


References
1.
Khan O, Cosgrove D, Wiltshaw E, Bland C, McCready V . Role of ultrasound in the management of ovarian carcinoma. J R Soc Med. 1983; 76(10):821-7. PMC: 1439587. DOI: 10.1177/014107688307601004. View

2.
Granowska M, Mather S, Britton K . Diagnostic evaluation of 111In and 99mTc radiolabelled monoclonal antibodies in ovarian and colorectal cancer: correlations with surgery. Int J Rad Appl Instrum B. 1991; 18(4):413-24. DOI: 10.1016/0883-2897(91)90069-w. View

3.
Crippa F, BURAGGI G, Di Re E, Gasparini M, Seregni E, Canevari S . Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody. Eur J Cancer. 1991; 27(6):724-9. DOI: 10.1016/0277-5379(91)90174-c. View

4.
Epenetos A, Britton K, Mather S, Shepherd J, Granowska M, Taylor-Papadimitriou J . Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours. Lancet. 1982; 2(8306):999-1005. DOI: 10.1016/s0140-6736(82)90046-0. View

5.
Granowska M, Mather S, Jobling T, Naeem M, Burchell J, Taylor-Papadimitriou J . Radiolabelled stripped mucin, SM3, monoclonal antibody for immunoscintigraphy of ovarian tumours. Int J Biol Markers. 1990; 5(2):89-96. DOI: 10.1177/172460089000500208. View